Ilex Medical Ltd (TLV:ILX)

Market Cap	671.29M -18.3%
Revenue (ttm)	917.10M -4.3%
Net Income	43.64M -20.4%
EPS	3.90 -20.2%
Shares Out	11.19M
PE Ratio	15.01
Forward PE	n/a
Dividend	1.22 (1.90%)
Ex-Dividend Date	Apr 7, 2025

Volume	19,082
Average Volume	1,487
Open	6,409.00
Previous Close	6,409.00
Day's Range	6,000.00 - 6,612.00
52-Week Range	5,643.00 - 7,664.00
Beta	-0.06
RSI	43.18
Earnings Date	Mar 26, 2026

About Ilex Medical

Ilex Medical Ltd engages in import, marketing, distribution, and sale of diagnostic products, kits, and consumables in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine, occult blood, calprotectin, LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1977
• Employees: 178
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, an increase of 0.45% compared to the previous year's 916.25 million. Earnings were 38.98 million, a decrease of -23.39%.